Ignite Creation Date:
2025-12-24 @ 5:45 PM
Ignite Modification Date:
2026-01-25 @ 4:33 AM
Study NCT ID:
NCT04681768
Status:
COMPLETED
Last Update Posted:
2025-09-26
First Post:
2020-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients
Sponsor:
Organization: